
Otis Brawley
Professor of Oncology and Epidemiology at Johns Hopkins University, expert in cancer trends and research.
Top 3 podcasts with Otis Brawley
Ranked by the Snipd community

Jul 11, 2025 • 1h 50min
Summer Friday: Contrapoints; Iconic New York Films; Cancer Research History & Roundtable
Natalie Wynn, the creator of the YouTube channel ContraPoints, dives into the psychology of conspiracy theories and their effects on democracy. Architect and filmmaker James Sanders shares insights on New York’s cinematic evolution, tracing its portrayal in film. Paul Goldberg and Otis Brawley discuss the history and future of cancer research, emphasizing the critical impact of funding on advancements and healthcare delivery, while touching on challenges within the U.S. system. This engaging conversation brings together diverse perspectives on culture, politics, and health.

Oct 16, 2024 • 45min
Why cancer among younger Americans is on the rise
Veda Giri, an expert in early onset cancers from Yale, and Rebecca Siegel, a cancer statistics specialist at the American Cancer Society, explore the rising rates of cancers among young Americans and the socio-economic factors at play. Stephen Rosenberg discusses groundbreaking advancements in immunotherapy, highlighting their potential to revolutionize treatment. Otis Brawley and Valerie Lee focus on the unique needs of younger colorectal cancer patients, stressing the importance of tailored care and addressing disparities in health outcomes.

Jan 21, 2024 • 17min
Disturbing Rise in Cancer Rates Among Younger Americans | 1.21.24
Dr. Otis Brawley, a Johns Hopkins oncology and epidemiology professor, discusses the alarming rise in cancer rates among younger Americans, particularly colorectal and pancreatic cancers. He highlights a yearly increase of 1-1.5% in colorectal cases, linking it to dietary changes and obesity. The conversation dives into microbial influences, like HPV and gut bacteria, and environmental factors like chemical exposure. Additionally, Dr. Brawley sheds light on the distinctions between familial and sporadic cancers and the implications for treatment and prognosis.